Position in DNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$273,238
+$14,731 QoQ
Shares Held
44,574
+43.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $195,980,910 across 162 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
126,044 | $13,438,811 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
181,647 | $10,393,841 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,469 | $10,075,173 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,918 | $9,925,509 | |
| 5 | RPRX |
Royalty Pharma plc
|
137,994 | $7,737,323 | |
| 6 | EXEL |
Exelixis, Inc.
|
110,353 | $6,004,306 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
16,302 | $4,645,580 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
108,139 | $4,640,244 |
All Filings in DNA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $273,238 | 44,574 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $258,507 | 31,108 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $441,708 | 39,263 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $155,427 | 27,268 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $516,355 | 52,582 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $3,582 | 10,727 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $137,556 | 118,583 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $72,796 | 39,138 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $25,297 | 10,629 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $335,881 | 40,419 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||